If it gets authorization, molnupiravir, which is designed to introduce errors into the genetic code of the virus, would be the first oral antiviral medication for COVID-19.
—
If the drug causes the virus to suffer transcription errors what assurance is there it won’t cause transcription errors with your own cells?
That thought also occurred to me.